These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3890730)

  • 1. Pharmacokinetics of ceftazidime, alone or in combination with piperacillin or tobramycin, in the sera of cancer patients.
    Drusano GL; Joshi J; Forrest A; Ruxer R; Standiford H; Leslie J; Wade J; Schimpff S
    Antimicrob Agents Chemother; 1985 Apr; 27(4):605-7. PubMed ID: 3890730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
    Marie JP; Marjanovic Z; Vekhoff A; Bouvet A; Chast F; Levy V; Baudard M; Legrand O; Rio B; Delmer A; Zittoun R
    Support Care Cancer; 1999 Mar; 7(2):89-94. PubMed ID: 10089089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group.
    De Pauw BE; Deresinski SC; Feld R; Lane-Allman EF; Donnelly JP
    Ann Intern Med; 1994 May; 120(10):834-44. PubMed ID: 8154643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Hess U; Böhme C; Rey K; Senn HJ
    Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of novel antipseudomonal drugs using the serum bactericidal activity test.
    Braveny I; Machka K; Milatovic D
    Eur J Clin Microbiol; 1986 Feb; 5(1):119-23. PubMed ID: 3084241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    Joshi JH; Newman KA; Brown BW; Finley RS; Ruxer RL; Moody MA; Schimpff SC
    Support Care Cancer; 1993 Jul; 1(4):186-94. PubMed ID: 8193880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
    Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
    Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serum concentrations of ceftazidime and tobramycin in newborn infants.
    Tessin I; Thiringer K; Trollfors B; Brorson JE
    Eur J Pediatr; 1988 May; 147(4):405-7. PubMed ID: 3294015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.
    Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2503-10. PubMed ID: 8585734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients.
    Kamonrattana R; Sathitsamitphong L; Choeyprasert W; Charoenkwan P; Natesirinilkul R; Fanhchaksai K
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2733-2737. PubMed ID: 31554370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection. Piperacillin/tazobactam Nosocomial Pneumonia Study Group.
    Joshi M; Bernstein J; Solomkin J; Wester BA; Kuye O
    J Antimicrob Chemother; 1999 Mar; 43(3):389-97. PubMed ID: 10223595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
    Cometta A; Zinner S; de Bock R; Calandra T; Gaya H; Klastersky J; Langenaeken J; Paesmans M; Viscoli C; Glauser MP
    Antimicrob Agents Chemother; 1995 Feb; 39(2):445-52. PubMed ID: 7726513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients.
    Fainstein V; Bodey GP; Elting L; Bolivar R; Keating MJ; McCredie KB; Valdivieso M
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():101-10. PubMed ID: 6352612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
    Peacock JE; Herrington DA; Wade JC; Lazarus HM; Reed MD; Sinclair JW; Haverstock DC; Kowalsky SF; Hurd DD; Cushing DA; Harman CP; Donowitz GR
    Ann Intern Med; 2002 Jul; 137(2):77-87. PubMed ID: 12118962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of five beta-lactam antibiotics against common nosocomial pathogens using the time above MIC at different creatinine clearances.
    Kays MB
    Pharmacotherapy; 1999 Dec; 19(12):1392-9. PubMed ID: 10600088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia.
    Kumar A; Hay MB; Maier GA; Dyke JW
    J Antimicrob Chemother; 1992 Nov; 30(5):597-602. PubMed ID: 1283606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
    Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of once- versus thrice-daily tobramycin in febrile neutropenic children undergoing stem cell transplantation.
    Sung L; Dupuis LL; Bliss B; Taddio A; Abdolell M; Allen U; Rolland M; Tong A; Taylor T; Doyle J
    J Natl Cancer Inst; 2003 Dec; 95(24):1869-77. PubMed ID: 14679156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of ceftazidime and tobramycin in patients with normal and impaired renal function.
    Aronoff GR; Brier RA; Sloan RS; Brier ME
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1139-42. PubMed ID: 2203304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxalactam and piperacillin: a study of in vitro characteristics and pharmacokinetics in cancer patients.
    Drusano GL; de Jongh C; Newman K; Joshi J; Wharton R; Moody MR; Schimpff SC
    Infection; 1985; 13(1):20-6. PubMed ID: 3988351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.